A detailed history of Virtus Investment Advisers, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 77,897 shares of ADMA stock, worth $1.36 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
77,897
Previous 157,268 50.47%
Holding current value
$1.36 Million
Previous $1.76 Million 11.43%
% of portfolio
1.3%
Previous 1.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $889,748 - $1.59 Million
-79,371 Reduced 50.47%
77,897 $1.56 Million
Q4 2023

Feb 15, 2024

BUY
$3.08 - $4.52 $259,868 - $381,365
84,373 Added 115.75%
157,268 $710,000
Q3 2023

Nov 08, 2023

BUY
$3.47 - $4.61 $43,243 - $57,449
12,462 Added 20.62%
72,895 $260,000
Q2 2023

Aug 14, 2023

BUY
$3.12 - $4.22 $188,550 - $255,027
60,433 New
60,433 $222,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Virtus Investment Advisers, Inc. Portfolio

Follow Virtus Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.